Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Exenatide

Exenatide Once Weekly for Smoking Cessation

AstraZeneca · Phase 1/2 · Completed · Enrollment 84

NCT02975297

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Exenatide plus NRT plus counselingn/rn/rn/rn/r
Placebo plus NRT plus counselingn/rn/rn/rn/r

Not shown

  • Exenatide plus NRT plus counseling: endpoint not reported
  • Placebo plus NRT plus counseling: endpoint not reported